Compare Stocks: BOT, RENE, RAC, and IGX

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IGX IntelGenx Technologies	C$0.58 +1.8%	C$0.58	C$0.17 ▼ C$0.85	C$87.32M	N/A	56,279 shs	11,848 shs
RENE Cartesian Growth Co. II	$11.21	$11.11	$10.52 ▼ $11.92	$242.36M	-0.01	62,761 shs	14,898 shs

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IGX IntelGenx Technologies	0.00%	0.00%	0.00%	0.00%	0.00%
RENE Cartesian Growth Co. II	+0.09%	+0.22%	+0.90%	+1.72%	+6.56%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IGX IntelGenx Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IGX IntelGenx Technologies	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IGX IntelGenx Technologies	C$1.75M	49.95	C$0.08 per share	7.16	C$0.05 per share	12.89
RENE Cartesian Growth Co. II	N/A	N/A	$0.40 per share	28.14	($0.64) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IGX IntelGenx Technologies	N/A	-C$0.08	N/A	∞	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	$11.44M	N/A	0.00	∞	N/A	N/A	-65.59%	5.02%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IGX IntelGenx Technologies	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IGX IntelGenx Technologies	164.62	2.77	2.69
RENE Cartesian Growth Co. II	N/A	0.22	0.22

Ownership

Institutional Ownership

Company	Institutional Ownership
IGX IntelGenx Technologies	N/A
RENE Cartesian Growth Co. II	58.96%

Insider Ownership

Company	Insider Ownership
IGX IntelGenx Technologies	N/A
RENE Cartesian Growth Co. II	20.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
IGX IntelGenx Technologies	48	150.55 million	N/A	Not Optionable
RENE Cartesian Growth Co. II	N/A	21.62 million	17.30 million	Not Optionable

BOT, RENE, RAC, and IGX Headlines

Source	Headline
	Short Interest in Cartesian Growth Co. II (NASDAQ:RENE) Increases By 312.5% marketbeat.com - April 25 at 10:22 PM
	Wolverine Asset Management LLC Acquires 104,768 Shares of Cartesian Growth Co. II (NASDAQ:RENE) marketbeat.com - April 23 at 8:48 PM
	Cartesian Growth Co. II (NASDAQ:RENE) Shares Up 0% americanbankingnews.com - April 19 at 2:58 AM
	Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Update marketbeat.com - March 28 at 8:23 PM

Media Sentiment Over Time

Top Headlines

Pagaya Technologies: An AI Fintech That Insiders Are Buying
April 24, 2024 11:12 AM
View Pagaya Technologies: An AI Fintech That Insiders Are Buying
3 High Dividend Stocks to Replace Lower Savings Yields Ahead
April 9, 2024 9:15 AM
View 3 High Dividend Stocks to Replace Lower Savings Yields Ahead
Analysts are Bullish on These 4 Oversold Large Cap Stocks
April 1, 2024 11:37 AM
View Analysts are Bullish on These 4 Oversold Large Cap Stocks
3 Key Stocks Helping to Drive the EV Race
April 12, 2024 9:25 AM
View 3 Key Stocks Helping to Drive the EV Race
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
April 12, 2024 7:32 AM
View 2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding

All Headlines

Company Descriptions

IntelGenx Technologies

CVE:IGX

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Cartesian Growth Co. II

NASDAQ:RENE

Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.

Compare Stocks